Live-cell imaging of caspase activation for high-content screening Journal Article


Authors: Antczak, C.; Takagi, T.; Ramirez, C. N.; Radu, C.; Djaballah, H.
Article Title: Live-cell imaging of caspase activation for high-content screening
Abstract: Caspases are central to the execution of programmed cell death, and their activation constitutes the biochemical hallmark of apoptosis. In this article, the authors report the successful adaptation of a high-content assay method using the DEVDNucView488ĝ.,¢ fluorogenic substrate, and for the first time, they show caspase activation in live cells induced by either drugs or siRNA. The fluorogenic substrate was found to be nontoxic over an exposure period of several days, during which the authors demonstrate automated imaging and quantification of caspase activation of the same cell population as a function of time. Overexpression of the antiapoptotic protein Bcl-XL, alone or in combination with the inhibitor Z-VAD-FMK, attenuated caspase activation in HeLa cells exposed to doxorubicin, etoposide, or cell death siRNA. This method was further validated against 2 well-characterized NSCLC cell lines reported to be sensitive (H3255) or refractory (H2030) to erlotinib, where the authors show a differential time-dependent activation was observed for H3255 and no significant changes in H2030, consistent with their respective chemosensitivity profile. In summary, the results demonstrate the feasibility of using this newly adapted and validated high-content assay to screen chemical or RNAi libraries for the identification of previously uncovered enhancers and suppressors of the apoptotic machinery in live cells. © 2009 Society for Biomolecular Sciences.
Keywords: controlled study; unclassified drug; human cell; doxorubicin; erlotinib; antineoplastic agents; cell proliferation; cell death; cell survival; gene overexpression; apoptosis; models, biological; etoposide; lung non small cell cancer; small interfering rna; cancer cell culture; enzyme activation; high throughput screening; drug screening assays, antitumor; caspase; chemical ht screening; high-content assay; live cells; rnai ht screening; aspartylglutamylvalyl aspartic acid; benzyloxycarbonylvalylalanylaspartyl fluoromethyl ketone; caspase inhibitor; peptide; protein bcl xl; cell population; chemosensitivity; enzyme substrate; gene library; hela cell; molecular imaging; amino acid chloromethyl ketones; bcl-x protein; caspases; cell line, tumor; cysteine proteinase inhibitors; diagnostic imaging; hela cells; high-throughput screening assays; transfection
Journal Title: Journal of Biomolecular Screening
Volume: 14
Issue: 8
ISSN: 1087-0571
Publisher: Sage Publications  
Date Published: 2009-09-01
Start Page: 956
End Page: 969
Language: English
DOI: 10.1177/1087057109343207
PUBMED: 19726787
PROVIDER: scopus
PMCID: PMC3613133
DOI/URL:
Notes: --- - "Cited By (since 1996): 9" - "Export Date: 30 November 2010" - "CODEN: JBISF" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Toshimitsu Takagi
    6 Takagi
  2. Hakim Djaballah
    101 Djaballah
  3. Christophe Antczak
    40 Antczak
  4. Constantin Radu
    28 Radu
  5. Christina Nicole Ramirez
    10 Ramirez